Your browser doesn't support javascript.
loading
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial.
Smolen, Josef S; Cohen, Stanley B; Tony, Hans-Peter; Scheinberg, Morton; Kivitz, Alan; Balanescu, Andra; Gomez-Reino, Juan; Cen, Liyi; Poetzl, Johann; Shisha, Tamas; Kollins, Dmitrij.
Afiliação
  • Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • Cohen SB; Department of Rheumatology, Metroplex Clinical Research Center, Dallas, TX, USA.
  • Tony HP; Department of Internal Medicine, Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany.
  • Scheinberg M; Rheumatology Section, Orthopedic Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
  • Kivitz A; Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, PA, USA.
  • Balanescu A; Sf. Maria Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Gomez-Reino J; Fundacion IDIS, Hospital Clinico Universitario, Santiago, Spain.
  • Cen L; Biostatistics Biosimilars Analytics, Novartis Pharmaceuticals Corp, East Hanover, NJ, USA.
  • Poetzl J; Biosimilar Clinical Development, Hexal AG, Holzkirchen, Germany.
  • Shisha T; Translational Medicine, Novartis Institute of Biomedical Research, Basel, Switzerland.
  • Kollins D; Biosimilar Clinical Development, Hexal AG, Holzkirchen, Germany.
Rheumatology (Oxford) ; 60(1): 256-262, 2021 01 05.
Article em En | MEDLINE | ID: mdl-32699904
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Rituximab Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Rituximab Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article